phenprocoumon and Spinal-Cord-Diseases

phenprocoumon has been researched along with Spinal-Cord-Diseases* in 2 studies

Other Studies

2 other study(ies) available for phenprocoumon and Spinal-Cord-Diseases

ArticleYear
[Intracranial and intraspinal hemorrhages in treatment with coumarin derivatives. Catamnesis of 63 cases between 1978 and 1986].
    Klinische Wochenschrift, 1987, Aug-17, Volume: 65, Issue:16

    From 1978-1986, 63 patients (48-79 years) under coumarin derivatives had to be hospitalized neurosurgically because of intracranial or intraspinal bleedings. This corresponds to a twelvefold increased risk compared to the untreated people. The male/female ratio was 1.5. At the time of the bleeding there was no true indication for anticoagulation in at least 60% of the patients. 80% with coma on admission died. Only for 2/7 with an intraspinal hemorrhage the outcome was better than paraplegic. Women proved to have a better chance of survival. There is a need for more concise indications for chronic anticoagulation.

    Topics: Acenocoumarol; Aged; Cerebral Hemorrhage; Coma; Coumarins; Female; Follow-Up Studies; Hematoma, Subdural; Hemorrhage; Humans; Male; Middle Aged; Paraplegia; Phenprocoumon; Risk Factors; Spinal Cord Diseases

1987
Anticoagulant therapy for radiation necrosis.
    Journal of neurosurgery, 1985, Volume: 62, Issue:4

    Topics: 4-Hydroxycoumarins; Adult; Female; Humans; Phenprocoumon; Radiation Injuries; Spinal Cord Diseases

1985